Steven T. Szabo

4.2k total citations · 1 hit paper
70 papers, 2.9k citations indexed

About

Steven T. Szabo is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Steven T. Szabo has authored 70 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 18 papers in Molecular Biology and 13 papers in Cognitive Neuroscience. Recurrent topics in Steven T. Szabo's work include Neuroscience and Neuropharmacology Research (18 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Receptor Mechanisms and Signaling (11 papers). Steven T. Szabo is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Receptor Mechanisms and Signaling (11 papers). Steven T. Szabo collaborates with scholars based in United States, Canada and Hungary. Steven T. Szabo's co-authors include Pierre Blier, Mark S. Gold, Dan J. Stein, Nathan A. Shapira, Toby D. Goldsmith, Mary Lessig, Claude de Montigny, Peixiong Yuan, Gopalkumar Rakesh and Husseini K. Manji and has published in prestigious journals such as Nature Medicine, Journal of Neuroscience and American Journal of Psychiatry.

In The Last Decade

Steven T. Szabo

70 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Problematic internet use: Proposed classification and diagnostic criteria

2003 584 citations Steven T. Szabo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven T. Szabo United States	28	937	545	511	501	485	70	2.9k
Sabine M. Grüsser Germany	23	861 0.9×	613 1.1×	1.1k 2.1×	294 0.6×	202 0.4×	43	3.0k
Elise E. DeVito United States	32	895 1.0×	285 0.5×	820 1.6×	425 0.8×	413 0.9×	84	3.0k
Jaeuk Hwang South Korea	26	613 0.7×	354 0.6×	729 1.4×	541 1.1×	252 0.5×	73	2.6k
R. Andrew Chambers United States	24	1.6k 1.7×	190 0.3×	936 1.8×	592 1.2×	640 1.3×	60	4.0k
Pietro Bria Italy	38	678 0.7×	358 0.7×	1.6k 3.1×	1.2k 2.4×	286 0.6×	103	4.9k
Aaron M. White United States	38	1.6k 1.7×	215 0.4×	1.1k 2.1×	204 0.4×	367 0.8×	63	5.5k
Alexandra Potter United States	26	491 0.5×	189 0.3×	916 1.8×	624 1.2×	1.1k 2.2×	63	3.3k
Andrew Smolen United States	44	1.4k 1.5×	323 0.6×	769 1.5×	770 1.5×	904 1.9×	138	6.4k
Michael C. Neale United States	18	466 0.5×	240 0.4×	426 0.8×	582 1.2×	471 1.0×	25	4.4k
Marco Di Nicola Italy	41	571 0.6×	423 0.8×	493 1.0×	1.4k 2.9×	253 0.5×	168	5.1k

Countries citing papers authored by Steven T. Szabo

Since Specialization

Citations

This map shows the geographic impact of Steven T. Szabo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven T. Szabo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven T. Szabo more than expected).

Fields of papers citing papers by Steven T. Szabo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven T. Szabo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven T. Szabo. The network helps show where Steven T. Szabo may publish in the future.

Co-authorship network of co-authors of Steven T. Szabo

This figure shows the co-authorship network connecting the top 25 collaborators of Steven T. Szabo. A scholar is included among the top collaborators of Steven T. Szabo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven T. Szabo. Steven T. Szabo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siegel, Joshua S., Jinglin Zhong, Stephen V. Faraone, et al.. (2025). Estimating heterogeneity of treatment effect in psychiatric clinical trials. Journal of Psychiatric Research. 191. 798–808. 1 indexed citations

Cohen, Alex S., Mark Opler, Brian Kirkpatrick, et al.. (2024). Evaluating speech latencies during structured psychiatric interviews as an automated objective measure of psychomotor slowing. Psychiatry Research. 340. 116104–116104. 2 indexed citations

Smith, Colin M., et al.. (2024). Xanomeline-trospium (Cobenfy^TM) for Schizophrenia: A Review of the Literature. Clinical Psychopharmacology and Neuroscience. 23(1). 2–14. 9 indexed citations

Siegel, Joshua S., Alex S. Cohen, Steven T. Szabo, et al.. (2024). Enrichment using speech latencies improves treatment effect size in a clinical trial of bipolar depression. Psychiatry Research. 340. 116105–116105. 3 indexed citations

Szabo, Steven T., Seth C. Hopkins, Robert Lew, et al.. (2023). A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy. Sleep Medicine. 107. 202–211. 5 indexed citations

Masand, Prakash, et al.. (2021). Mental Health and COVID-19: Challenges and Multimodal Clinical Solutions. Journal of Psychiatric Practice. 27(4). 254–264. 3 indexed citations

Hollander, Jonathan A., Deborah A. Cory‐Slechta, Felice N. Jacka, et al.. (2020). Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease. Neuropsychopharmacology. 45(7). 1086–1096. 46 indexed citations

Krystal, Andrew D., Diego A. Pizzagalli, Moria J. Smoski, et al.. (2020). A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia. Nature Medicine. 26(5). 760–768. 155 indexed citations

Rakesh, Gopalkumar, Nicholas Mischel, Bruce Luber, et al.. (2019). Theta Burst for Cognitive Remediation in Schizophrenia. Journal of Ect. 36(1). 72–74. 1 indexed citations

10.

Ward, Heather Burrell, Steven T. Szabo, & Gopalkumar Rakesh. (2018). Maintenance ECT in schizophrenia: A systematic review. Psychiatry Research. 264. 131–142. 31 indexed citations

11.

Krystal, Andrew D., Diego A. Pizzagalli, Sanjay J. Mathew, et al.. (2018). The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development. Nature Reviews Drug Discovery. 18(1). 82–84. 45 indexed citations

12.

Muzyk, Andrew J., Jane P. Gagliardi, Gopalkumar Rakesh, et al.. (2017). Development of a Diverse Learning Experience for Diverse Psychiatry Resident Needs: A Four-Year Biological Psychiatry Curriculum Incorporating Principles of Neurobiology, Psychopharmacology, and Evidence-Based Practice. Psychiatry Investigation. 14(3). 289–289. 4 indexed citations

13.

Naylor, Jennifer C., Jason D. Kilts, Steven T. Szabo, et al.. (2015). Allopregnanolone Levels Are Inversely Associated with Self-Reported Pain Symptoms in U.S. Iraq and Afghanistan-Era Veterans: Implications for Biomarkers and Therapeutics. Pain Medicine. 17(1). 25–32. 14 indexed citations

14.

Lee, Tong H., Steven T. Szabo, Paolo Mannelli, et al.. (2012). Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: A novel treatment strategy. Drug and Alcohol Dependence. 124(1-2). 11–18. 5 indexed citations

15.

Szabo, Steven T. & Pierre Blier. (2002). Effects of Serotonin (5-Hydroxytryptamine, 5-HT) Reuptake Inhibition Plus 5-HT2A Receptor Antagonism on the Firing Activity of Norepinephrine Neurons. Journal of Pharmacology and Experimental Therapeutics. 302(3). 983–991. 77 indexed citations

16.

Szabo, Steven T. & Pierre Blier. (2001). Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons. European Journal of Neuroscience. 13(11). 2077–2087. 90 indexed citations

17.

Szabo, Steven T.. (2001). Food for thought. Annals of Emergency Medicine. 38(2). 184–185. 1 indexed citations

18.

Szabo, Steven T. & Pierre Blier. (2001). Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Research. 922(1). 9–20. 116 indexed citations

19.

Szabo, Steven T., et al.. (1988). Effects of thyrotropin-releasing hormone and its analogue L-6-ketopiperidine-2-carbonyl-leucyl-L-prolin-amide on behaviour and electroencephalogram.. PubMed. 38(8). 1134–8. 10 indexed citations

20.

Es, Reynolds, et al.. (1976). Modulation of halothane and vinyl chloride induced acute injury to liver endoplastic reticulum.. PubMed. 18(9-10). 367–74. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact